Not applicableNot Yet RecruitingNCT06432855What this trial is testingGenetic Determinants of the Antiviral Immune Response in Oceanian PopulationsWho this might be right forVirus Institut Pasteur 220
Not applicableStudy completedNCT01945008What this trial is testingObservational Study in HCV Chronic InfectionWho this might be right forHepatitis C, Chronic Istituto Superiore di Sanità 7,600
Post-approval studies (Phase 4)UnknownNCT04267458What this trial is testingPrevalence of Kidney Injury in Patients With HCV Treated With Sofuspovir Containing DAA TherapyWho this might be right forInvestigate the Renal Effect of DAAs on Egyption Patients After Completion of Treatment Cairo University 300
Not applicableUnknownNCT04039698What this trial is testingMonitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in BrazilWho this might be right forChronic Hepatitis C Hospital de Clinicas de Porto Alegre 144
Not applicableStudy completedNCT03246048What this trial is testingLong Term Follow-up of Hepatitis C Cured PatientsWho this might be right forChronic Hepatitis CChronic Liver DiseaseCirrhosis Hospital Universitari Vall d'Hebron Research Institute 300
Not applicableStudy completedNCT00001000What this trial is testingAtvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of InfectionWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT01464827What this trial is testingABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected PatientsWho this might be right forChronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1 AbbVie (prior sponsor, Abbott) 580
Testing effectiveness (Phase 2)Study completedNCT00919854What this trial is testingA Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected ChildrenWho this might be right forHuman Immunodeficiency Virus 1 Tibotec Pharmaceuticals, Ireland 27
Not applicableUnknownNCT06041022What this trial is testingA Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis BWho this might be right forHepatitis B, Chronic Qilu Hospital of Shandong University 1,000
Large-scale testing (Phase 3)Study completedNCT02967939What this trial is testingEfficacy and Safety of DA-2802 in Chronic Hepatitis B PatientsWho this might be right forHepatitis B, Chronic Dong-A ST Co., Ltd. 123
Large-scale testing (Phase 3)Ended earlyNCT01872988What this trial is testingTenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular CarcinomaWho this might be right forChronic Hepatitis BHepatocellular Carcinoma Taichung Veterans General Hospital 320
Not applicableStudy completedNCT03342261What this trial is testingBenefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed CryoglobulinemiaWho this might be right forHepatitis C, ChronicMixed Cryoglobulinemia Hospices Civils de Lyon 47
Testing effectiveness (Phase 2)Study completedNCT00120861What this trial is testingValopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard TherapyWho this might be right forChronic Hepatitis C Merck Sharp & Dohme LLC
Not applicableUnknownNCT06452069What this trial is testingEfficacy and Safety Study of Essential Oil-Based Preparation Administered to COVID-19 PatientsWho this might be right forCOVID-19 Respiratory InfectionCOVID-19 Biodex S.A 280
Testing effectiveness (Phase 2)Study completedNCT03491553What this trial is testingSafety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis BWho this might be right forChronic Hepatitis B Gilead Sciences 48
Not applicableUnknownNCT04220151What this trial is testingEpigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis CWho this might be right forHepatocellular Carcinoma Assiut University 100
Early research (Phase 1)Study completedNCT03739866What this trial is testingStudy to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected AdultsWho this might be right forHIV-1 Infection Gilead Sciences 53
Testing effectiveness (Phase 2)Study completedNCT01057667What this trial is testingRO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 168
Testing effectiveness (Phase 2)Study completedNCT02485509What this trial is testingStudy of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 InfectionWho this might be right forHIV Infection Viriom 28
Early research (Phase 1)Study completedNCT04423393What this trial is testingStudy of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus InfectionWho this might be right forChronic Hepatitis B Vir Biotechnology, Inc. 113